Prognostic implications of I-123 metaiodobenzylguanidine (MIBG) in patients with idiopathic dilated cardiomyopathy (DCM) and receiving β-blockade treatment
Hiroyuki Kakuchi, Tatsuya Sasaki, Yoshio Ishida, Shuuji Fukuoka, Kunio MiyatakeVolume:
27
Year:
1996
Language:
english
DOI:
10.1016/s0735-1097(96)80297-x
File:
PDF, 169 KB
english, 1996